Investing

Innoviva : INVA

INVA

Stock Data

$23.11

$0.12 (0.52%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Innoviva Inc is a biopharmaceutical company focused on the development and commercialization of medicines for various respiratory conditions. Its portfolio includes RELVAR/BREO ELLIPTA and ANORO ELLIPTA for chronic obstructive pulmonary disease and asthma, as well as treatments for high blood pressure in shock patients and complicated intra-abdominal infections. Innoviva also works on developing new treatments, such as a potential single-dose cure for gonorrhea. Originally named Theravance, the company rebranded to Innoviva in 2016 and is based in Burlingame, California.

All Innoviva Articles

1 Article

Will Ashworth | Mar 17, 2025 at 3:01 PM EDT

Billionaire Healthcare Investor Alex Denner’s Hedge Fund Has 75% of Its Assets in These 3 Stocks 

If you work in the biotech industry, you might know the name Alex Denner. If not, his name probably doesn’t…